Patients of advanced age and cardiovascular diseases or diabetes have alterations in ACE expression and Ang II signaling [84–86], likely rendering them more susceptible to further repercussions of ACE/ACE2 imbalance. This evidence concerns the gene ACE and cardiovascular disorder.